Where can I find ACRV's financial statements?

Acrivon Therapeutics, Inc. Common Stock (ACRV)'s full income statement, balance sheet, and cash flow statement are on this page in 10-K-style line-item format. Switch between the three statements via the pill toggle above the table.

How much history is available for ACRV?

Acrivon Therapeutics, Inc. Common Stock (ACRV) statements are available back to its earliest filed 10-K — typically 10+ years of annual data and 40 quarters of quarterly data. Free-tier users see 5 years and 8 quarters; full history unlocks with a Pro account.

How often does ACRV update its statements?

Acrivon Therapeutics, Inc. Common Stock files a 10-K annually (full audited year-end statements) and 10-Q reports quarterly (unaudited interim statements). New filings are typically parsed and reflected on this page within 48 hours of SEC submission.

ACRV

Acrivon Therapeutics, Inc. Common Stock

NASDAQ·Biotechnology · Healthcare

$2.06$0.09−4.19%

Pre-market·$2.03−1.46%

Market cap$88.17M·Market closed·Aug 28 8:00 PM UTC

USD · values shown as reported

Line item	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	Trend
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Cost of revenue	—	—	$536.00K	$1.01M+87.7%	$1.36M+34.8%
Gross profit	$0.00+100.0%	$0.00	−$536.00K	−$1.01M−87.7%	−$1.36M−34.8%
Research & development	$13.72M+633.6%	$23.95M+74.6%	$45.49M+89.9%	$63.99M+40.7%	$59.99M−6.3%
General & administrative	$2.47M+90.0%	$8.71M+253.1%	$21.08M+142.1%	$25.21M+19.6%	$24.12M−4.3%
Selling & marketing	—	—	$134.00K	—	—	—
SG&A (combined)	$2.47M+90.0%	$8.71M+253.1%	$21.21M+143.6%	$25.21M+18.8%	$24.12M−4.3%
Other operating expenses	—	—	—	−$1.01M	−$1.36M−34.8%
Total operating expenses	$16.18M+410.9%	$32.66M+101.8%	$66.70M+104.2%	$88.19M+32.2%	$82.76M−6.2%
Operating income	−$16.18M−410.9%	−$32.66M−101.8%	−$67.24M−105.9%	−$89.20M−32.7%	−$84.11M+5.7%
Interest income	—	—	$7.04M	$9.20M+30.8%	$6.48M−29.6%
Other income / (expense), net	−$59.00K+97.2%	$1.49M+2,625.4%	$6.85M+359.7%	$8.64M+26.2%	$6.21M−28.2%
Income before tax	−$16.24M−206.1%	−$31.17M−91.9%	−$60.39M−93.8%	−$80.56M−33.4%	−$77.91M+3.3%
Net income	−$16.24M−206.1%	−$31.17M−91.9%	−$60.39M−93.8%	−$80.56M−33.4%	−$77.91M+3.3%

EPS (basic)	−$1.26−207.3%	−$1.42−12.7%	−$2.74−93.0%	−$2.10+23.4%	−$2.02+3.8%
EPS (diluted)	−$1.26−207.3%	−$1.42−12.7%	−$2.74−93.0%	−$2.10+23.4%	−$2.02+3.8%
Weighted avg shares (basic)	12,909,823	21,920,634	22,078,190	38,296,428	38,509,281
Weighted avg shares (diluted)	12,909,823	21,920,634	22,078,190	38,296,428	38,509,281

Depreciation & amortization	$37.00K+184.6%	$364.00K+883.8%	$536.00K+47.3%	$1.01M+87.7%	$1.36M+34.8%
EBITDA	−$16.21M−206.2%	−$30.80M−90.1%	−$59.85M−94.3%	−$79.55M−32.9%	−$76.55M+3.8%

Frequently Asked Questions About ACRV

Where can I find ACRV's financial statements?: Acrivon Therapeutics, Inc. Common Stock (ACRV)'s full income statement, balance sheet, and cash flow statement are on this page in 10-K-style line-item format. Switch between the three statements via the pill toggle above the table.
How much history is available for ACRV?: Acrivon Therapeutics, Inc. Common Stock (ACRV) statements are available back to its earliest filed 10-K — typically 10+ years of annual data and 40 quarters of quarterly data. Free-tier users see 5 years and 8 quarters; full history unlocks with a Pro account.
How often does ACRV update its statements?: Acrivon Therapeutics, Inc. Common Stock files a 10-K annually (full audited year-end statements) and 10-Q reports quarterly (unaudited interim statements). New filings are typically parsed and reflected on this page within 48 hours of SEC submission.